Flow cytometric analysis of P-glycoprotein expression and drug efflux in human soft tissue and bone sarcomas

Hiroshi Kunikane, Mark M. Zalupski, Cheppail Ramachandran, Mark A. Kukuruga, David Lucas, James R. Ryan, Awtar Krishan

Research output: Contribution to journalArticle

15 Citations (Scopus)

Abstract

Twenty-two fresh surgical specimens of human sarcomas (soft tissue and bone) from 20 patients were analyzed by flow cytometry for the expression of drug resistance-related P-glycoprotein (P-gp) and cellular daunorubicin (DNR) accumulation with or without the presence of DNR efflux blockers. Single-cell suspensions prepared from the tumor specimens were analyzed by dual-color flow cytometry after reaction with MRK-16 (anti-P-gp) and anti- CD45 (pan-leukocyte) antibodies. MRK-16 reactivity of tumor cells was evaluated after exclusion of CD45-positive cells by electronic gates. Parallel samples were incubated with DNR alone or in combination with DNR efflux blockers, verapamil (VPL), or dipyridamole (DPD) for determination of cellular DNR accumulation and the effect of the efflux blockers. Extensive heterogeneity was observed in both P-gp expression and DNR accumulation of the tumor specimens examined. Eight of the 22 tumor specimens had significant numbers of P-gp-positive cells. In three of the eight P-gp- positive tumors, cellular DNR accumulation was significantly increased by co-incubation with the efflux blockers VPL or DPD. These results indicate that both quantitative and functional analysis of P-gp expression may he essential in determining the cellular drug resistance phenotype of tumor cells and its correlation with therapeutic outcome.

Original languageEnglish
Pages (from-to)197-203
Number of pages7
JournalCommunications in Clinical Cytometry
Volume30
Issue number4
DOIs
StatePublished - Aug 15 1997
Externally publishedYes

Fingerprint

Daunorubicin
P-Glycoprotein
Sarcoma
Pharmaceutical Preparations
Neoplasms
Dipyridamole
Verapamil
Drug Resistance
Flow Cytometry
Suspensions
Leukocytes
Color
Phenotype
Bone and Bones
Antibodies

Keywords

  • Bone sarcoma
  • Daunorubicin
  • Drug efflux
  • Flow cytometry
  • Multidrug resistance
  • P- glycoprotein
  • Soft tissue sarcoma

ASJC Scopus subject areas

  • Hematology
  • Cell Biology
  • Pathology and Forensic Medicine
  • Biophysics
  • Endocrinology

Cite this

Flow cytometric analysis of P-glycoprotein expression and drug efflux in human soft tissue and bone sarcomas. / Kunikane, Hiroshi; Zalupski, Mark M.; Ramachandran, Cheppail; Kukuruga, Mark A.; Lucas, David; Ryan, James R.; Krishan, Awtar.

In: Communications in Clinical Cytometry, Vol. 30, No. 4, 15.08.1997, p. 197-203.

Research output: Contribution to journalArticle

Kunikane, Hiroshi ; Zalupski, Mark M. ; Ramachandran, Cheppail ; Kukuruga, Mark A. ; Lucas, David ; Ryan, James R. ; Krishan, Awtar. / Flow cytometric analysis of P-glycoprotein expression and drug efflux in human soft tissue and bone sarcomas. In: Communications in Clinical Cytometry. 1997 ; Vol. 30, No. 4. pp. 197-203.
@article{eb51014f1bba439aa09a2529185cc407,
title = "Flow cytometric analysis of P-glycoprotein expression and drug efflux in human soft tissue and bone sarcomas",
abstract = "Twenty-two fresh surgical specimens of human sarcomas (soft tissue and bone) from 20 patients were analyzed by flow cytometry for the expression of drug resistance-related P-glycoprotein (P-gp) and cellular daunorubicin (DNR) accumulation with or without the presence of DNR efflux blockers. Single-cell suspensions prepared from the tumor specimens were analyzed by dual-color flow cytometry after reaction with MRK-16 (anti-P-gp) and anti- CD45 (pan-leukocyte) antibodies. MRK-16 reactivity of tumor cells was evaluated after exclusion of CD45-positive cells by electronic gates. Parallel samples were incubated with DNR alone or in combination with DNR efflux blockers, verapamil (VPL), or dipyridamole (DPD) for determination of cellular DNR accumulation and the effect of the efflux blockers. Extensive heterogeneity was observed in both P-gp expression and DNR accumulation of the tumor specimens examined. Eight of the 22 tumor specimens had significant numbers of P-gp-positive cells. In three of the eight P-gp- positive tumors, cellular DNR accumulation was significantly increased by co-incubation with the efflux blockers VPL or DPD. These results indicate that both quantitative and functional analysis of P-gp expression may he essential in determining the cellular drug resistance phenotype of tumor cells and its correlation with therapeutic outcome.",
keywords = "Bone sarcoma, Daunorubicin, Drug efflux, Flow cytometry, Multidrug resistance, P- glycoprotein, Soft tissue sarcoma",
author = "Hiroshi Kunikane and Zalupski, {Mark M.} and Cheppail Ramachandran and Kukuruga, {Mark A.} and David Lucas and Ryan, {James R.} and Awtar Krishan",
year = "1997",
month = "8",
day = "15",
doi = "10.1002/(SICI)1097-0320(19970815)30:4<197::AID-CYTO7>3.0.CO;2-H",
language = "English",
volume = "30",
pages = "197--203",
journal = "Cytometry Part B - Clinical Cytometry",
issn = "1552-4949",
publisher = "Wiley-Liss Inc.",
number = "4",

}

TY - JOUR

T1 - Flow cytometric analysis of P-glycoprotein expression and drug efflux in human soft tissue and bone sarcomas

AU - Kunikane, Hiroshi

AU - Zalupski, Mark M.

AU - Ramachandran, Cheppail

AU - Kukuruga, Mark A.

AU - Lucas, David

AU - Ryan, James R.

AU - Krishan, Awtar

PY - 1997/8/15

Y1 - 1997/8/15

N2 - Twenty-two fresh surgical specimens of human sarcomas (soft tissue and bone) from 20 patients were analyzed by flow cytometry for the expression of drug resistance-related P-glycoprotein (P-gp) and cellular daunorubicin (DNR) accumulation with or without the presence of DNR efflux blockers. Single-cell suspensions prepared from the tumor specimens were analyzed by dual-color flow cytometry after reaction with MRK-16 (anti-P-gp) and anti- CD45 (pan-leukocyte) antibodies. MRK-16 reactivity of tumor cells was evaluated after exclusion of CD45-positive cells by electronic gates. Parallel samples were incubated with DNR alone or in combination with DNR efflux blockers, verapamil (VPL), or dipyridamole (DPD) for determination of cellular DNR accumulation and the effect of the efflux blockers. Extensive heterogeneity was observed in both P-gp expression and DNR accumulation of the tumor specimens examined. Eight of the 22 tumor specimens had significant numbers of P-gp-positive cells. In three of the eight P-gp- positive tumors, cellular DNR accumulation was significantly increased by co-incubation with the efflux blockers VPL or DPD. These results indicate that both quantitative and functional analysis of P-gp expression may he essential in determining the cellular drug resistance phenotype of tumor cells and its correlation with therapeutic outcome.

AB - Twenty-two fresh surgical specimens of human sarcomas (soft tissue and bone) from 20 patients were analyzed by flow cytometry for the expression of drug resistance-related P-glycoprotein (P-gp) and cellular daunorubicin (DNR) accumulation with or without the presence of DNR efflux blockers. Single-cell suspensions prepared from the tumor specimens were analyzed by dual-color flow cytometry after reaction with MRK-16 (anti-P-gp) and anti- CD45 (pan-leukocyte) antibodies. MRK-16 reactivity of tumor cells was evaluated after exclusion of CD45-positive cells by electronic gates. Parallel samples were incubated with DNR alone or in combination with DNR efflux blockers, verapamil (VPL), or dipyridamole (DPD) for determination of cellular DNR accumulation and the effect of the efflux blockers. Extensive heterogeneity was observed in both P-gp expression and DNR accumulation of the tumor specimens examined. Eight of the 22 tumor specimens had significant numbers of P-gp-positive cells. In three of the eight P-gp- positive tumors, cellular DNR accumulation was significantly increased by co-incubation with the efflux blockers VPL or DPD. These results indicate that both quantitative and functional analysis of P-gp expression may he essential in determining the cellular drug resistance phenotype of tumor cells and its correlation with therapeutic outcome.

KW - Bone sarcoma

KW - Daunorubicin

KW - Drug efflux

KW - Flow cytometry

KW - Multidrug resistance

KW - P- glycoprotein

KW - Soft tissue sarcoma

UR - http://www.scopus.com/inward/record.url?scp=0030848542&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0030848542&partnerID=8YFLogxK

U2 - 10.1002/(SICI)1097-0320(19970815)30:4<197::AID-CYTO7>3.0.CO;2-H

DO - 10.1002/(SICI)1097-0320(19970815)30:4<197::AID-CYTO7>3.0.CO;2-H

M3 - Article

C2 - 9298839

AN - SCOPUS:0030848542

VL - 30

SP - 197

EP - 203

JO - Cytometry Part B - Clinical Cytometry

JF - Cytometry Part B - Clinical Cytometry

SN - 1552-4949

IS - 4

ER -